| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.058 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |